🔗 Visit the ClinicalTrials.gov page for NCT00688194
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer. | J Clin Oncol | 2011 | 2.10 |
| 2 | Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer. | Breast Cancer (Dove Med Press) | 2012 | 0.79 |
| 3 | Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer. | Breast Cancer (Dove Med Press) | 2011 | 0.79 |
| 4 | Management of ErbB2-positive breast cancer: insights from preclinical and clinical studies with lapatinib. | Jpn J Clin Oncol | 2010 | 0.79 |